Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro.

MLA

Freund CTF, et al. “Combination of Adenovirus-Mediated Thymidine Kinase Gene Therapy with Cytotoxic Chemotherapy in Bladder Cancer in Vitro.” Urologic Oncology, vol. 21, no. 3, May 2003, pp. 197–205. EBSCOhost, https://doi.org/10.1016/s1078-1439(02)00241-7.

APA

Freund CTF, Tong X, Rowley D, Engehausen D, Frolov A, Kieback DG, Lerner SP, Freund, C. T. F., Tong, X.-W., Rowley, D., Engehausen, D., Frolov, A., Kieback, D. G., & Lerner, S. P. (2003). Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro. Urologic Oncology, 21(3), 197–205. https://doi.org/10.1016/s1078-1439(02)00241-7

Chicago

Freund CTF, Tong X, Rowley D, Engehausen D, Frolov A, Kieback DG, Lerner SP, et al. 2003. “Combination of Adenovirus-Mediated Thymidine Kinase Gene Therapy with Cytotoxic Chemotherapy in Bladder Cancer in Vitro.” Urologic Oncology 21 (3): 197–205. doi:10.1016/s1078-1439(02)00241-7.